โ† All ADM Flashcard Decks

Ethical, Legal, & Regulatory Considerations in Addiction Medicine Flashcards

7 cards from real ADM practice questions. Tap to flip, then mark Knew It or Still Learning โ€” missed cards come back until you master them.

Read the first 7 Ethical, Legal, & Regulatory Considerations in Addiction Medicine flashcards as text
  1. A state's prescription drug monitoring program (PDMP) report reveals a patient is receiving opioids from three different providers. Which action best reflects both legal and ethical obligations?

    Answer: Contact the patient for a clinical conversation and coordinate with other prescribers after obtaining consent

    PDMP data should prompt a non-judgmental clinical conversation and care coordination; patient safety is the priority while confidentiality and therapeutic alliance are preserved.

  2. Which federal law establishes parity between mental health/substance use disorder benefits and medical/surgical benefits in insurance coverage?

    Answer: The Mental Health Parity and Addiction Equity Act (MHPAEA)

    MHPAEA requires that coverage limitations for mental health and substance use disorder benefits be no more restrictive than those for medical and surgical benefits.

  3. A patient with opioid use disorder who is pregnant refuses buprenorphine treatment. The most ethically defensible physician response is to:

    Answer: Respect the patient's autonomy, provide comprehensive counseling, and continue to offer treatment

    Patient autonomy must be respected; the physician should provide thorough counseling about risks, document the discussion, and keep the therapeutic relationship open for future engagement.

  4. The DATA 2000 (Drug Addiction Treatment Act) was historically significant in addiction medicine because it:

    Answer: Allowed qualified physicians to prescribe Schedule III-V narcotic medications for opioid use disorder in office-based settings

    DATA 2000 allowed DEA-waivered physicians to prescribe buprenorphine (Schedule III) for opioid use disorder treatment outside of opioid treatment programs for the first time.

  5. Which of the following scenarios most clearly represents a conflict of interest in addiction medicine practice?

    Answer: All of the above

    All three scenarios involve relationships or incentives that could impair clinical objectivity and professional judgment, constituting conflicts of interest.

  6. Under what circumstances may a substance use disorder treatment program disclose patient information to law enforcement without patient consent under 42 CFR Part 2?

    Answer: When a patient commits a crime on program premises or against program personnel

    42 CFR Part 2 permits disclosure to law enforcement only when the crime is committed on program premises or against program personnel, without requiring patient consent.

  7. A physician prescribing buprenorphine is ethically obligated to establish and maintain which of the following with each patient?

    Answer: A therapeutic alliance with clear treatment goals, informed consent, and ongoing monitoring

    Ethical MOUD practice centers on therapeutic alliance, individualized treatment goals, informed consent, and evidence-based monitoring rather than punitive contingencies.